1. Polanczyk G, Rohde LA (2007) Epidemiology of attention-deficit/hyperactivity disorder across the lifespan. Curr Opin Psychiatry 20(4):386–92
2. Fayyad J, De GR, Kessler R, Alonso J, Angermeyer M, Demyttenaere K et al (2007) Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 190:402–9
3. Danish National Board of Health. [Guide to medicamental treatment of children and adolescents with psychiatric disorders] [ https://www retsinformation dk/Forms/R0710 aspx?id = 114817]; Last updated: 12-10-2010].
4. Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC (2011) et al. ADHD Drugs and Serious Cardiovascular Events in Children and Young Adults, N Engl J Med
5. Smith G, Jongeling B, Hartman P (2010) RUssell C, Landou L. Long-term outcomes associated with stimulation medication in the treatment of ADHD in children. Government of Western Australia; Published in, Raine ADHD Study